Sanofi leans on COPD as 'next major growth pillar' for its immunology star Dupixent: CEO

25th April 2024 Uncategorised 0

Sanofi leans on COPD as ‘next major growth pillar’ for its immunology star Dupixent: CEO
fkansteiner
Thu, 04/25/2024 – 11:32

More: Sanofi leans on COPD as 'next major growth pillar' for its immunology star Dupixent: CEO
Source: fierce